At Aepril Clinics, we offer the following treatments: Ozempic A GLP-1 receptor agonist containing the active ingredient semaglutide, originally developed for the treatment of type 2 diabetes
Yet the Lipovia patch claims to deliver GLP-1 effects transdermally through nanotechnology. Scientifically, thats impossible with current technology
While these effects are primarily targeted at metabolic regulation and weight loss, they also have indirect impacts on the hormonal systems that control the menstrual cycle
Contraindications include personal or family history of medullary thyroid carcinoma, MEN2 syndrome, acute pancreatitis, or severe renal impairment
This finding was later combined with research by Joel Habener and jointly published in JCI
[19] [4] As with semaglutide, use is subject to defined eligibility criteria and specialist oversight